Geode Capital Management
OREX

Geode Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Geode Capital Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-59,849
Closed -$77K – 4153
2017
Q4 		$77K Sell
59,849
-4,379
-7% -$7.13K ﹤0.01% 3870
2017
Q3 		$136K Hold
64,228
– – ﹤0.01% 3757
2017
Q2 		$186K Sell
64,228
-1,892
-3% -$5.67K ﹤0.01% 3710
2017
Q1 		$227K Buy
66,120
+258
+0.4% +$1.02K ﹤0.01% 3613
2016
Q4 		$114K Buy
65,862
+172
+0.3% +$404 ﹤0.01% 3764
2016
Q3 		$218K Sell
65,690
-2
-0% -$8 ﹤0.01% 3567
2016
Q2 		$282K Sell
65,692
-10,540
-14% -$47.7K ﹤0.01% 3450
2016
Q1 		$428 Sell
76,232
-2,187
-3% -$28.4K ﹤0.01% 3312
2015
Q4 		$1.35M Buy
78,419
+4,355
+6% +$104K ﹤0.01% 2745
2015
Q3 		$1.56M Buy
74,064
+3,034
+4% +$104K ﹤0.01% 2599
2015
Q2 		$3.52M Buy
71,030
+110
+0.2% +$6.58K ﹤0.01% 2143
2015
Q1 		$5.55M Buy
70,920
+2,564
+4% +$159K ﹤0.01% 1801
2014
Q4 		$4.14M Buy
68,356
+3,123
+5% +$157K ﹤0.01% 1925
2014
Q3 		$2.78M Buy
65,233
+1,025
+2% +$55K ﹤0.01% 2163
2014
Q2 		$3.97M Buy
64,208
+10,914
+20% +$635K ﹤0.01% 1932
2014
Q1 		$3.46M Buy
53,294
+11,032
+26% +$746K ﹤0.01% 2009
2013
Q4 		$2.38M Buy
42,262
+1,070
+3% +$60.1K ﹤0.01% 2188
2013
Q3 		$2.53M Buy
41,192
+4,767
+13% +$323K ﹤0.01% 2030
2013
Q2 		$2.13M Buy
+36,425
New +$2.24M ﹤0.01% 1994

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's OREX Position: Q1 2018 in Review

Geode Capital Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 59,849 shares — an estimated $77K sold.

Geode Capital Management first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $5.55M in Q1 2015. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

  • Geode Capital Management reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Geode Capital Management sold 59,849 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $77K.
  • Geode Capital Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
  • Geode Capital Management's Orexigen Therapeutics, Inc. position peaked at $5.55M in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.